vs

Side-by-side financial comparison of Everus Construction Group, Inc. (ECG) and Teradyne (TER). Click either name above to swap in a different company.

Teradyne is the larger business by last-quarter revenue ($1.3B vs $1.0B, roughly 1.3× Everus Construction Group, Inc.). Teradyne runs the higher net margin — 31.1% vs 5.5%, a 25.6% gap on every dollar of revenue. On growth, Teradyne posted the faster year-over-year revenue change (87.0% vs 33.2%). Over the past eight quarters, Teradyne's revenue compounded faster (32.6% CAGR vs 27.1%).

Teradyne, Inc. is an American automatic test equipment (ATE) designer and manufacturer based in North Reading, Massachusetts. Its high-profile customers include Samsung, Qualcomm, Intel, Analog Devices, Texas Instruments and IBM.

ECG vs TER — Head-to-Head

Bigger by revenue
TER
TER
1.3× larger
TER
$1.3B
$1.0B
ECG
Growing faster (revenue YoY)
TER
TER
+53.9% gap
TER
87.0%
33.2%
ECG
Higher net margin
TER
TER
25.6% more per $
TER
31.1%
5.5%
ECG
Faster 2-yr revenue CAGR
TER
TER
Annualised
TER
32.6%
27.1%
ECG

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
ECG
ECG
TER
TER
Revenue
$1.0B
$1.3B
Net Profit
$55.3M
$398.9M
Gross Margin
11.6%
60.9%
Operating Margin
6.8%
36.9%
Net Margin
5.5%
31.1%
Revenue YoY
33.2%
87.0%
Net Profit YoY
60.4%
EPS (diluted)
$1.09
$2.53

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ECG
ECG
TER
TER
Q1 26
$1.3B
Q4 25
$1.0B
$1.1B
Q3 25
$986.8M
$769.2M
Q2 25
$921.5M
$651.8M
Q1 25
$826.6M
$685.7M
Q4 24
$759.6M
$752.9M
Q3 24
$761.0M
$737.3M
Q2 24
$703.4M
$729.9M
Net Profit
ECG
ECG
TER
TER
Q1 26
$398.9M
Q4 25
$55.3M
$257.2M
Q3 25
$57.0M
$119.6M
Q2 25
$52.8M
$78.4M
Q1 25
$36.7M
$98.9M
Q4 24
$34.5M
$146.3M
Q3 24
$41.8M
$145.6M
Q2 24
$39.0M
$186.3M
Gross Margin
ECG
ECG
TER
TER
Q1 26
60.9%
Q4 25
11.6%
57.2%
Q3 25
12.6%
58.4%
Q2 25
13.0%
57.2%
Q1 25
11.2%
60.6%
Q4 24
11.4%
59.4%
Q3 24
11.8%
59.2%
Q2 24
12.6%
58.3%
Operating Margin
ECG
ECG
TER
TER
Q1 26
36.9%
Q4 25
6.8%
27.1%
Q3 25
7.3%
18.9%
Q2 25
7.9%
13.9%
Q1 25
6.2%
17.6%
Q4 24
6.1%
20.4%
Q3 24
7.1%
20.6%
Q2 24
7.3%
28.8%
Net Margin
ECG
ECG
TER
TER
Q1 26
31.1%
Q4 25
5.5%
23.7%
Q3 25
5.8%
15.5%
Q2 25
5.7%
12.0%
Q1 25
4.4%
14.4%
Q4 24
4.5%
19.4%
Q3 24
5.5%
19.8%
Q2 24
5.5%
25.5%
EPS (diluted)
ECG
ECG
TER
TER
Q1 26
$2.53
Q4 25
$1.09
$1.62
Q3 25
$1.11
$0.75
Q2 25
$1.03
$0.49
Q1 25
$0.72
$0.61
Q4 24
$0.68
$0.89
Q3 24
$0.82
$0.89
Q2 24
$0.76
$1.14

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ECG
ECG
TER
TER
Cash + ST InvestmentsLiquidity on hand
$241.9M
Total DebtLower is stronger
$281.5M
$0
Stockholders' EquityBook value
$629.8M
Total Assets
$1.7B
$4.4B
Debt / EquityLower = less leverage
0.45×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ECG
ECG
TER
TER
Q1 26
$241.9M
Q4 25
$293.8M
Q3 25
$272.7M
Q2 25
$339.3M
Q1 25
$475.6M
Q4 24
$553.4M
Q3 24
$553.0K
$510.0M
Q2 24
$421.9M
Total Debt
ECG
ECG
TER
TER
Q1 26
$0
Q4 25
$281.5M
Q3 25
$285.1M
Q2 25
$288.6M
Q1 25
$292.1M
Q4 24
$295.6M
Q3 24
Q2 24
Stockholders' Equity
ECG
ECG
TER
TER
Q1 26
Q4 25
$629.8M
$2.8B
Q3 25
$573.0M
$2.7B
Q2 25
$514.4M
$2.8B
Q1 25
$460.2M
$2.8B
Q4 24
$422.6M
$2.8B
Q3 24
$453.3M
$2.9B
Q2 24
$490.0M
$2.7B
Total Assets
ECG
ECG
TER
TER
Q1 26
$4.4B
Q4 25
$1.7B
$4.2B
Q3 25
$1.6B
$4.0B
Q2 25
$1.5B
$3.8B
Q1 25
$1.4B
$3.7B
Q4 24
$1.3B
$3.7B
Q3 24
$1.3B
$3.8B
Q2 24
$3.6B
Debt / Equity
ECG
ECG
TER
TER
Q1 26
Q4 25
0.45×
Q3 25
0.50×
Q2 25
0.56×
Q1 25
0.63×
Q4 24
0.70×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ECG
ECG
TER
TER
Operating Cash FlowLast quarter
$48.2M
$265.1M
Free Cash FlowOCF − Capex
$23.5M
FCF MarginFCF / Revenue
2.3%
Capex IntensityCapex / Revenue
2.4%
Cash ConversionOCF / Net Profit
0.87×
0.66×
TTM Free Cash FlowTrailing 4 quarters
$90.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ECG
ECG
TER
TER
Q1 26
$265.1M
Q4 25
$48.2M
$281.6M
Q3 25
$76.2M
$49.0M
Q2 25
$25.3M
$182.1M
Q1 25
$7.1M
$161.6M
Q4 24
$282.6M
Q3 24
$78.9M
$166.3M
Q2 24
$216.1M
Free Cash Flow
ECG
ECG
TER
TER
Q1 26
Q4 25
$23.5M
$218.8M
Q3 25
$65.7M
$2.4M
Q2 25
$12.3M
$131.7M
Q1 25
$-11.4M
$97.6M
Q4 24
$225.2M
Q3 24
$60.9M
$114.4M
Q2 24
$171.2M
FCF Margin
ECG
ECG
TER
TER
Q1 26
Q4 25
2.3%
20.2%
Q3 25
6.7%
0.3%
Q2 25
1.3%
20.2%
Q1 25
-1.4%
14.2%
Q4 24
29.9%
Q3 24
8.0%
15.5%
Q2 24
23.5%
Capex Intensity
ECG
ECG
TER
TER
Q1 26
Q4 25
2.4%
5.8%
Q3 25
1.1%
6.1%
Q2 25
1.4%
7.7%
Q1 25
2.2%
9.3%
Q4 24
7.6%
Q3 24
2.4%
7.0%
Q2 24
6.1%
Cash Conversion
ECG
ECG
TER
TER
Q1 26
0.66×
Q4 25
0.87×
1.09×
Q3 25
1.34×
0.41×
Q2 25
0.48×
2.32×
Q1 25
0.19×
1.63×
Q4 24
1.93×
Q3 24
1.89×
1.14×
Q2 24
1.16×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ECG
ECG

Commercial$594.5M59%
Utility$203.5M20%
Industrial$82.8M8%
Institutional$66.1M7%
Service And Other$28.4M3%
Transportation$24.2M2%
Renewables$19.8M2%

TER
TER

Segment breakdown not available.

Related Comparisons